- Investigator
- Mark G Bandyk
- Status
- Accepting Candidates
- Ages
- 18 Years - 101 Years
- Sexes
- All
Treats Adults
Mark G Bandyk, MD, MPH, MS
Urologist
Mark G Bandyk, MD, MPH, MS
(904) 383-1016
Request appointment online
Research at a glance
Top areas of exploration
- Urinary Bladder Neoplasms , 7 publications
- Prostatic Neoplasms , 6 publications
- Postoperative Complications , 4 publications
- Cystectomy , 3 publications
Research activity
Active clinical trials
My publications
Filter publications
25 publications
2022
Inter-reader reliability of the vesical imaging-reporting and data system (VI-RADS) for muscle-invasive bladder cancer: a systematic review and meta-analysis.
Abdominal radiology (New York)
鈥�2022
Combination therapy in metastatic castration sensitive prostate cancer: A Systematic review and network meta-analysis.
Indian journal of urology : IJU : journal of the Urological Society of India
鈥�2022
The Geriatric Nutritional Risk Index Predicts Postoperative Outcomes in Bladder Cancer: A Propensity Score-Matched Analysis.
The Journal of urology
鈥�2022
Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.
Urologic oncology
鈥�2021
Pathology grade influences competing mortality risks in elderly men with prostate cancer.
Urologic oncology
鈥�